Anauxetic Dysplasia Type 1

Anauxetic dysplasia type 1 (ANXD1) is the most severe end of the cartilage-hair hypoplasia–anauxetic dysplasia (CHH-AD) spectrum, a group of skeletal dysplasias caused by biallelic variants in the non-coding RMRP gene. ANXD1 presents with prenatal-onset, extreme short-limb short stature, characteristic spine and long-bone changes, joint laxity, craniofacial/dental anomalies, and it may include atlanto-axial subluxation and mild intellectual disability. Immune, hematologic, and gastrointestinal issues span the CHH-AD spectrum and can occur in ANXD1 to variable degrees. NCBI

ANXD1 results from pathogenic variants in RMRP, which encodes the RNA component of the RNase MRP ribonucleoprotein complex. This complex helps process RNA inside cells (including steps that influence cell division and ribosome biogenesis). When RMRP is faulty, the growth and maturation of cartilage and bone are profoundly disturbed, producing the skeletal pattern seen in ANXD1; immune and blood-cell issues reflect the same basic RNA-processing defect in other tissues. MedlinePlus

Anauxetic dysplasia type 1 is a very rare genetic bone growth disorder. It begins before birth and causes extreme short stature (dwarfism) with short limbs and multiple skeletal changes. Many people also have very flexible joints, dental problems, and distinctive facial features. In some patients there can be spinal instability at the top of the neck (atlantoaxial subluxation) that may compress the spinal cord and cause neurological symptoms unless recognized and treated. ANXD1 sits at the most severe end of a family of related conditions called the cartilage–hair hypoplasia–anauxetic dysplasia (CHH-AD) spectrum. Unlike the “cartilage-hair hypoplasia” end of the spectrum, the hair and immune system can be normal in anauxetic dysplasia in many patients; the main problems are skeletal. ANXD1 is autosomal recessive—you must inherit a faulty copy of the gene from each parent. NCBI+1

Other names

You may see ANXD1 described by several alternate names in the literature:

• Anauxetic dysplasia (AD)

• Spondylometaepiphyseal dysplasia, anauxetic type

• Spondylometaepiphyseal dysplasia, Menger type
  All of these refer to essentially the same clinical picture; when the genetic cause is specified as RMRP (see below), that is type 1. MedlinePlus+1

Why it happens

ANXD1 is caused by harmful changes (variants) in a gene called RMRP on chromosome 9. Unlike most genes, RMRP does not make a protein. Instead, it makes a non-coding RNA that forms the heart of an enzyme called RNase MRP. RNase MRP helps cells process ribosomal RNA (rRNA)—a key ingredient needed to build ribosomes, the tiny factories that make proteins in every cell. Faulty RMRP → faulty RNase MRP → rRNA processing problems → ribosome manufacturing is off. Growing cartilage cells in the growth plate (chondrocytes) are very sensitive to this. As a result, endochondral bone growth is severely disrupted, causing the hallmark skeletal findings and very short stature from the prenatal period onward. MedlinePlus

ANXD1 belongs to a spectrum of disorders that all arise from RMRP variants; at the milder end is metaphyseal dysplasia without hypotrichosis, in the middle is cartilage-hair hypoplasia (CHH), and the most severe skeletal form is anauxetic dysplasia. How severe a person becomes seems to relate to how much the RMRP change reduces its function. NCBI

Note: Another, closely related condition called anauxetic dysplasia type 2 (ANXD2) is caused by changes in POP1, a protein partner of RNase MRP. The clinical picture overlaps, but ANXD2 is genetically distinct. This guide focuses on type 1 (RMRP-related). MedlinePlus

Types

Within the anauxetic dysplasia group, clinicians usually distinguish by gene:

• Type 1 (ANXD1) — RMRP-related, autosomal recessive. This is the topic of this guide. MedlinePlus+1

• Type 2 (ANXD2) — POP1-related, autosomal recessive, with very similar skeletal signs; listed here only to clarify nomenclature. MedlinePlus

Clinically, ANXD1 is also framed as the severe end of the CHH-AD spectrum. This helps doctors think about prognosis and surveillance, because some management principles are shared across the spectrum. NCBI

Causes

These “causes” are different ways RMRP function can be reduced or why a person ends up with two non-working copies. Each item is a short paragraph in simple English.

1. Two harmful RMRP variants (autosomal recessive inheritance)
   ANXD1 occurs when a child inherits one non-working RMRP copy from each parent. Parents are usually healthy carriers. NCBI+1

2. RMRP changes that alter the RNA structure
   Some variants change the RNA’s shape so RNase MRP cannot assemble or work efficiently, cutting rRNA processing capacity. MedlinePlus

3. Promoter or regulatory variants
   Changes in non-coding control regions can lower how much RMRP RNA is made, starving RNase MRP of its core component. (Mechanism summarized from the RMRP biology in MedlinePlus Genetics.) MedlinePlus

4. Splice-affecting variants in RMRP
   Some variants disturb how the RMRP transcript is produced or trimmed, leading to defective or unstable RNA. (General mechanism inferred from non-coding RNA variant effects described across the spectrum.) NCBI

5. Large deletions or copy-number changes at the RMRP locus
   Rarely, a deletion removes critical parts of RMRP, leaving little or no functional RNA. (GeneReviews notes deletions and the need for methods beyond simple sequencing.) NCBI

6. Uniparental isodisomy causing “double dose” of a bad variant
   Very rarely, a child may inherit two copies of the same parental chromosome segment carrying the bad RMRP variant, creating homozygosity without two carrier parents. NCBI

7. Compound heterozygosity
   The two copies of RMRP can carry different harmful variants; together they reduce function below the threshold needed for normal growth. NCBI

8. Reduced RNase MRP assembly
   If altered RMRP RNA cannot bind its protein partners properly, the enzyme complex is unstable and underperforms. MedlinePlus

9. Defective ribosomal RNA processing
   RNase MRP normally helps cut precursor rRNA into usable pieces. When this step falters, ribosome production is inefficient, and fast-dividing growth-plate cells suffer. MedlinePlus

10. Broad “ribosomopathy” effects on chondrocytes
    Cartilage cells in the growth plate need high protein synthesis rates. Ribosome shortages slow their proliferation and maturation, shortening bones. MedlinePlus

11. Disturbed cell-cycle regulation
    RMRP dysfunction impairs cell growth signaling; this adds to poor cartilage expansion in the growth plate. (Supported by human genetic data showing RMRP is an “essential cell growth regulator”.) MedlinePlus

12. Prenatal onset because endochondral ossification is hit early
    Because the growth plate drives fetal limb elongation, early RMRP-related disruption produces short limbs already on prenatal scans. NCBI

13. Severity tied to the degree of RMRP functional loss
    Studies across the spectrum show that more severe RMRP impairment tracks with more severe skeletal disease, placing AD at the extreme. MedlinePlus

14. Population genetics (consanguinity increases risk in families)
    In communities where parents are related, two carriers are more likely to have a child with two bad copies. (General autosomal-recessive principle; GeneReviews discusses carrier states and recurrence.) NCBI

15. Mosaicism in a parent (rare)
    A parent with a variant in some egg or sperm cells could have more than one affected child even if standard testing seems negative. (General genetic counseling point referenced in GeneReviews’ counseling framework.) NCBI

16. RMRP variants that spare hair/immune pathways
    Why some patients have prominent bone disease with little hair or immune involvement is not fully known; gene-function differences likely steer the phenotype toward AD. NCBI

17. Misdiagnosis delays
    Not a molecular cause, but clinically important: delayed recognition of cervical instability can worsen cord compression and function. Early diagnosis prevents secondary damage. NCBI

18. Overlap with other RNase MRP partner gene defects (context)
    While POP1 changes cause ANXD2 (not type 1), this shows that weakening the same enzyme from different angles can create a similar skeletal picture—helpful when building gene panels. MedlinePlus

19. Founder variants in specific families
    Individual families or small populations may carry recurring private RMRP variants that recur in siblings. (GeneReviews notes family-level recurrence and carrier testing.) NCBI

20. Gene-to-phenotype variability within the spectrum
    Even with the same RMRP variant, people can differ in severity, suggesting other genes or environment modify the effect. This variability is well documented for the CHH-AD spectrum. NCBI

Common symptoms and signs

1. Extreme short stature from birth
   Babies are small with very short arms and legs. Adult height is often less than 85 cm without surgical lengthening. NCBI

2. Disproportionate body build
   Limbs are much shorter than the trunk (short-limb dwarfism). This is seen on physical exam and X-rays. NCBI

3. Very flexible (lax) joints
   Ligaments are loose, so elbows, knees, and other joints may bend more than usual and feel unstable. NCBI

4. Hip problems
   Hips may be dislocated or shallow. This can cause limping and early pain with walking. NCBI+1

5. Spine curvature
   A rounded upper back with side-to-side curve (kyphoscoliosis) and excess low-back curve (hyperlordosis) are common. They may progress with growth. MedlinePlus

6. Neck spine instability (atlantoaxial subluxation)
   The top two neck vertebrae can be unstable. This risks spinal cord compression and neurological symptoms if not identified. MedlinePlus

7. Breathing problems from chest shape
   A barrel-shaped chest and severe kyphoscoliosis can restrict lung expansion and cause breathlessness. MedlinePlus

8. Dental problems (hypodontia)
   There may be fewer teeth than usual or teeth may be missing in certain areas. MedlinePlus

9. Facial features
   Often midface hypoplasia, closely spaced eyes, large tongue, and a prominent chin. These features help clinicians recognize the condition. MedlinePlus

10. Hand and foot differences
    Hands can show “bullet-shaped” middle finger bones and cone-shaped growth centers on X-rays; feet may be rocker-bottom in infants. NCBI+1

11. Gait differences and frequent falls
    Hip, knee, and spine problems change balance and walking pattern, especially as curves progress. NCBI

12. Back pain
    As curves and instability progress, muscle fatigue and mechanical back pain are common. NCBI

13. Neurologic symptoms if the cord is compressed
    Neck instability can cause numbness, tingling, weakness, poor coordination, or even paralysis without prompt care. MedlinePlus

14. Mild intellectual disability (in some)
    Some people with ANXD1 have mild cognitive differences, though many have normal cognition. NCBI+1

15. Normal hair and (often) normal immune system
    Compared to the “cartilage-hair hypoplasia” end of the spectrum, hair can be normal and immune problems are not a defining feature in ANXD1. NCBI

Diagnostic tests

(Grouped as requested: Physical exam, Manual tests, Lab/Pathology, Electrodiagnostic, Imaging. Each test includes what it checks and why it matters.)

A) Physical examination

1. Detailed growth and body-proportion exam
   Measure height, sitting height, arm span, and limb lengths. Disproportionate short-limb stature strongly suggests a skeletal dysplasia like ANXD1. NCBI

2. Spine and posture assessment
   Look for kyphoscoliosis and hyperlordosis. Progression of curves guides timing of bracing or surgery. NCBI

3. Joint laxity and stability check
   Assess elbows, knees, hips, ankles for excessive motion and instability, which are common and affect walking. NCBI

4. Craniofacial and dental review
   Note midface hypoplasia, macroglossia, and missing teeth (hypodontia). These features support the clinical diagnosis. MedlinePlus

5. Neurological screening
   Check strength, reflexes, sensation, and gait. Any abnormalities raise concern for cervical cord compression and trigger urgent imaging. MedlinePlus

B) Manual bedside tests

6. Beighton score for hypermobility
   A simple 9-point maneuver set helps quantify joint laxity and track change over time in ANXD1. (General hypermobility tool applied to this phenotype.) NCBI

7. Adams forward-bend test
   A quick screen for rib hump and scoliosis severity; positive findings direct formal imaging and orthopedic referral. (Standard scoliosis screen used in dysplasias.) NCBI

8. Ortolani/Barlow maneuvers (infants)
   Gentle hip tests can detect developmental dislocation early, allowing bracing or surgical planning. (Standard neonatal hip exam techniques.) NCBI

9. Galeazzi sign
   A bedside leg-length and knee-height comparison that suggests hip dysplasia or dislocation. (Orthopedic screening principle.) NCBI

10. Functional gait assessment
    Observation of walking, balance, and endurance helps quantify disability from limb deformity and spinal curves. NCBI

C) Laboratory and pathological / genetic tests

11. Targeted RMRP sequencing (molecular confirmation)
    If clinical and X-ray findings suggest ANXD1, sequencing RMRP confirms the diagnosis. This allows family testing and reproductive counseling. NCBI

12. Broader skeletal dysplasia gene panel or exome/genome
    When the picture is unclear, multigene panels or trio exome/genome help, because many skeletal dysplasias look similar. NCBI

13. Copy-number analysis (deletions/duplications) at RMRP
    If sequencing is negative but suspicion is high, assess for larger structural variants that standard sequencing can miss. NCBI

14. Carrier testing for parents / relatives
    Once the family’s RMRP variants are known, offer carrier tests for relatives planning children. NCBI

15. Prenatal testing (CVS/amniocentesis) or preimplantation testing
    If both parental variants are known, targeted testing can be offered in a new pregnancy. NCBI

16. Basic labs to check for spectrum-related issues
    A complete blood count (for anemia) and simple immune studies are often normal in ANXD1, but can be considered because CHH (the milder spectrum end) can show these issues. NCBI

D) Electrodiagnostic / physiologic tests

17. EMG/nerve conduction studies (selected cases)
    If a person has limb numbness or weakness, studies can help distinguish spinal cord compression effects from a peripheral nerve problem when planning surgery. (Contextual use in cervical myelopathy care.) MedlinePlus

18. Pulmonary function testing (spirometry)
    Severe kyphoscoliosis and barrel chest can restrict lungs. Spirometry quantifies restriction and helps monitor benefit from bracing or surgery. (Standard in skeletal dysplasia with thoracic restriction.) MedlinePlus

E) Imaging tests

19. Full skeletal survey (X-rays of the whole skeleton)
    Shows classic features: ovoid, delayed-maturing vertebral bodies with concave back surfaces, metaphyseal and epiphyseal changes, and bullet-shaped finger bones with cone epiphyses. NCBI

20. Cervical spine flexion–extension X-rays
    Looks for atlantoaxial instability—a key, potentially dangerous complication that needs careful anesthesia planning or surgery. NCBI+1

21. Spine MRI (especially cervical)
    Evaluates spinal cord compression and soft tissues that X-rays cannot show. Critical when there are neurological signs. MedlinePlus

22. Standing EOS or long-film spine radiographs
    Low-dose, weight-bearing images track curve progression and pelvic/hip alignment over time to time interventions. (Orthopedic imaging principle applied to dysplasia.) NCBI

23. Pelvis and hip X-rays
    Define acetabular shallowness, hip subluxation or dislocation, and femoral head/neck hypoplasia that guide orthopedic care. MedlinePlus

24. Knee and ankle X-rays
    Identify metaphyseal flaring, irregular mineralization, and alignment deformities (varus/valgus) relevant to osteotomy planning. NCBI

25. Bone age study (left hand X-ray)
    Shows delayed or unusual growth-plate development and epiphyseal changes typical for this spectrum; helps counseling and timing of procedures. NCBI

Treatment

There is no curative drug that corrects the underlying RMRP defect. Care aims to protect the cervical spine and lungs, prevent and treat infections, manage anemia/hematologic issues, support nutrition and development, and correct deformities surgically when indicated. In severe immune disease or marrow failure across the spectrum, hematopoietic stem-cell transplantation (HSCT) can be considered; otherwise, management is supportive and individualized by a multidisciplinary team. NCBI

---

Practical, non-pharmacological care (evidence-guided)

Below are multidisciplinary supports that are commonly recommended. Because ANXD1 is extremely rare, formal randomized trials don’t exist; these measures are extrapolated from GeneReviews-level guidance and specialty practice within the CHH-AD spectrum.

1. Cervical spine protection & anesthesia precautions. Screen early for atlanto-axial instability; if present, use neck stabilization and alert anesthesiologists before any procedure. Spine surgery is considered for instability or compression. NCBI

2. Respiratory preservation. Progressive kypho-scoliosis can restrict lungs. Early physio-respiratory therapy, airway clearance, vaccination (as immunologic status allows), and timely surgical correction protect lung function. NCBI

3. Physiotherapy & joint protection. Gentle range-of-motion, core/hip strengthening, low-impact conditioning, and bracing reduce pain and delay deformity progression while avoiding hyperextension in lax joints. NCBI

4. Mobility aids & orthotics. Custom orthoses and mobility devices reduce falls and energy cost of ambulation; home and school ergonomic adaptations preserve independence. NCBI

5. Orthopedic surveillance. Scheduled spine and lower-limb imaging (particularly through growth) allows timely osteotomy for progressive varus/valgus deformity and planning for scoliosis surgery if respiratory compromise emerges. NCBI

6. Dental and craniofacial care. Early dental assessment for hypodontia and crowding; orthodontic and restorative planning improves chewing, speech, and airway mechanics. MedlinePlus

7. Nutritional support. Dietitian input for growth optimization; address malabsorption or short-bowel issues if present; ensure adequate calcium/vitamin D for bone health. NCBI

8. Infection-risk reduction. Hand hygiene, exposure avoidance, and vaccine planning (deferring live vaccines if immune dysfunction/SCID) are central; prompt evaluation for severe varicella is critical. NCBI

9. Pulmonary rehab for bronchiectasis. If recurrent chest infections or bronchiectasis are present, integrate airway-clearance techniques, pulmonary physio, and specialist follow-up. NCBI

10. Hematology follow-up. Monitor for macrocytic, hypoplastic anemia and manage per standard practice; transfusions and iron chelation are used as needed. NCBI

11. Developmental & educational supports. Speech/occupational therapy and individualized education plans address motor, speech, or cognitive needs. NCBI

12. Psychosocial care. Family counseling, peer support, and mental-health resources help with chronic-condition stress and social participation barriers. NCBI

13. Fertility & puberty counseling. Monitor pubertal development; manage hypogonadism if present and offer reproductive counseling in adulthood. NCBI

14. Cancer surveillance. Clinical screening for lymphoma/other malignancies is advised across the spectrum (intensity individualized). NCBI

15. Genetic counseling. Explain autosomal-recessive inheritance; offer carrier testing for relatives and prenatal/preimplantation testing if family variants are known. NCBI

---

Medicines you may see used (supportive; tailored to complications)

There isn’t a list of “anauxetic-dysplasia drugs.” Instead, clinicians use standard medications to prevent or treat complications identified in the CHH-AD spectrum. Choices depend on the person’s anatomy, immune status, blood counts, and imaging.

• Antimicrobials for infections (targeted antibiotics/antivirals/antifungals by culture/site). Early IV acyclovir for varicella is specifically recommended due to risk of severe disease. NCBI

• Prophylaxis for recurrent/severe infections, e.g., antibiotic prophylaxis in selected cases and immunoglobulin replacement (IVIG/SCIG) when humoral defects are documented. NCBI

• Vaccinations per immunology guidance: avoid live vaccines if immune evaluation shows significant T-cell dysfunction/SCID. Inactivated vaccines are used per schedule. NCBI

• Analgesics for musculoskeletal pain, starting with acetaminophen; NSAIDs used cautiously given GI/renal risks; adjuvants for neuropathic components as needed. (General symptomatic practice; no ANXD1-specific trials.) NCBI

• Hematology medications per findings (e.g., transfusion support and iron chelation if iron overload from repeated transfusions). NCBI

• Pulmonary medications for co-morbid airway disease (e.g., bronchodilators, inhaled steroids) guided by pulmonology if bronchiectasis/reactive airways coexist; primary therapy remains airway clearance. NCBI

Important: Agents sometimes used in other bone disorders (growth hormone, bisphosphonates) don’t have evidence of disease-modifying benefit in ANXD1; use outside a research or expert-center context is generally not recommended. (This is an inference from the absence of guideline support and the emphasis on supportive care in GeneReviews.) NCBI

---

Dietary “molecular” supplements

For ANXD1 there’s no supplement proven to change the disease course. Nutrition aims to support bone and immune health and address any malabsorption. Widely used adjuncts include:

• Vitamin D & calcium (to meet daily requirements, not “mega-doses”) to support bone mineralization alongside safe weight-bearing. NCBI

• General balanced macronutrient intake, adequate protein, and micronutrients per age/sex; tailor if short-bowel or malabsorption is present. NCBI

(If you need a deep dive on dosing targets for age/sex, I can build a table from pediatric and adult nutrition references; the disease literature itself does not specify unique dosing.)

---

Regenerative / immune-reconstituting therapies

• Hematopoietic stem-cell transplantation (HSCT). Considered in severe combined immunodeficiency, recurrent life-threatening infections, or severely depressed erythropoiesis within the CHH-AD spectrum. HSCT can correct hematologic/immune problems but does not correct skeletal dysplasia. NCBI

No gene-editing or cell-based skeletal regeneration therapies are yet established for ANXD1.

---

Surgeries you may encounter (why they’re done)

• Cervical fusion/decompression for atlanto-axial instability or cord compression to prevent paralysis and protect breathing. NCBI

• Scoliosis/kyphosis correction when curve progression compromises lung function or causes pain. NCBI

• Lower-limb corrective osteotomies for progressive varus/valgus deformities to improve alignment and mobility. NCBI

• Hip procedures for dislocation/dysplasia to relieve pain and improve function. NCBI

• Dental/craniofacial surgeries for hypodontia or airway mechanics (case-by-case). MedlinePlus

---

Prevention & everyday safety

• Infection prevention: hand hygiene, prompt care for fever, and vaccine planning with immunology. Avoid live vaccines if immune dysfunction is present. NCBI

• Spine safety: avoid forceful neck manipulation; share cervical-spine status with any anesthesiologist or therapist. NCBI

• Respiratory protection: early attention to coughs, airway clearance if needed, and sleep-disordered breathing screening if symptoms. NCBI

• Falls/ergonomics: home/school adaptations, orthoses, and mobility aids. NCBI

• Dental hygiene: early and regular dental care for hypodontia and malocclusion. MedlinePlus

• Healthy nutrition & weight-bearing activity within safe limits to support bone and lung health. NCBI

• Cancer vigilance: know the symptoms that warrant rapid assessment (persistent lymphadenopathy, night sweats, weight loss). NCBI

• Family planning: carrier testing for partners and options for prenatal/preimplantation testing when family variants are known. NCBI

---

When to see a doctor urgently

• Neck pain, new limb weakness, numbness, coordination problems, or bladder/bowel changes (possible cervical cord compression). MedlinePlus

• Breathing difficulty, worsening cough, high fever, or exposure to varicella—seek care promptly (may need IV acyclovir). NCBI

• Severe or recurrent infections; unusual bruising/pallor/fatigue (possible hematologic issues). NCBI

• Rapidly progressing spinal curve or new severe back pain. NCBI

---

What to eat vs. what to avoid (simple guidance)

• Emphasize: balanced meals with adequate protein, fruits/vegetables, whole grains; calcium and vitamin D to meet daily needs; sufficient fluids and fiber (if constipation). NCBI

• Limit/avoid: smoking exposure; excessive alcohol (adolescents/adults); extreme/imbalanced diets; unverified “bone-growth” supplements. There’s no proven diet that alters ANXD1 itself. NCBI

---

Fast facts (inheritance, names, codes)

• Gene: RMRP (non-coding RNA of RNase MRP). Inheritance: autosomal recessive. Aliases: part of the CHH-AD spectrum (with CHH and MDWH). Codes: OMIM 607095; Orphanet 93347; MONDO 0054560. NCBI+1

---

Frequently asked questions (FAQ)

1) Is there a cure or growth-promoting medicine for ANXD1?
No. Current care is supportive. Surgical correction of deformities and multidisciplinary management improve health and function; no drug restores normal bone growth in ANXD1. NCBI

2) Will my child always need neck precautions?
If atlanto-axial instability is present, yes—through surgery or activity modifications. Even without documented instability, clinicians avoid high-risk neck maneuvers and monitor over time. NCBI

3) Are vaccines safe?
Inactivated vaccines are generally used. Live vaccines are avoided if immune dysfunction/SCID is present. Decisions are individualized after immune evaluation. NCBI

4) Can HSCT fix the bones?
HSCT can correct severe immune/blood problems but does not reverse skeletal dysplasia. NCBI

5) What about POP1 and “type 2”?
ANXD1 = RMRP; ANXD2 = POP1. They look similar radiographically but are genetically distinct—important for counseling and testing relatives. MalaCards+1

6) How short will adult height be?
In ANXD1, adult height is typically <85 cm; variability exists across the CHH-AD spectrum. NCBI

7) Is pain inevitable?
Pain often relates to deformities and joint laxity; physiotherapy, bracing, ergonomic supports, and—when needed—surgery help. Analgesics are used cautiously. NCBI

8) Can pregnancy be carried safely?
Affected adults can have pregnancies, but due to cephalopelvic disproportion, a planned cesarean is often considered. NCBI

9) Is cancer risk higher?
Across the spectrum there’s an elevated risk for certain malignancies; surveillance is clinical and individualized by age and phenotype. NCBI

10) What specialists should be on the care team?
Genetics, orthopedics/spine surgery, pulmonology, immunology/hematology, dentistry/orthodontics, physiotherapy, nutrition, and psychology—coordinated in a center familiar with skeletal dysplasias. NCBI

11) Can special diets or supplements change the disease?
No diet or supplement has proven disease-modifying benefit; meet daily requirements and treat deficiencies. NCBI

12) Are there formal guidelines?
No disease-specific practice guidelines exist; GeneReviews synthesizes current best practice for the CHH-AD spectrum. NCBI

13) Is testing available for relatives?
Yes. Once the family’s RMRP variants are known, offer carrier testing and prenatal or preimplantation testing if desired. NCBI

14) What imaging is typical?
Annual spine and joint assessment in childhood (and as needed later) with radiographs; CT/MRI for suspected bronchiectasis or spinal cord compression. NCBI

15) Where to read more?
Start with GeneReviews (updated Aug 7, 2025) for CHH-AD and MedlinePlus Genetics for a patient-friendly overview. NCBI+1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 16, 2025.